NEW YORK (GenomeWeb News) — GE Healthcare may soon acquire Abbott Diagnostics in an attempt to fatten its molecular diagnostics play, according to news reports this morning.

GE has been eyeing the in vitro diagnostic space since it acquired Amersham in 2004, and the Abbott business could offer it a substantial position in that market.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.